Evidence map›Paper›PMID 34321945›Full record

ArticleJournal of blood medicine2021

Primary Cauda Equina Lymphoma Treated with CNS-Centric Approach: A Case Report and Literature Review.

Justin J Kuhlman, Muhamad Alhaj Moustafa, Vivek Gupta, Liuyan Jiang, Han W Tun

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of blood medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Primary Cauda Equina Lymphoma Mimicking Meningioma.Journal of clinical medicine · 2024
    Review
  5. Primary peripheral nerve lymphoma: a case report and literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Justin J KuhlmanDepartment of Internal Medicine, Mayo Clinic Florida, Jacksonville, FL, USA.ORCID 0000-0001-5970-4692
Muhamad Alhaj MoustafaDivision of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.ORCID 0000-0001-8582-1219
Vivek GuptaDepartment of Radiology, Mayo Clinic Florida, Jacksonville, FL, USA.
Liuyan JiangDepartment of Pathology and Laboratory Medicine, Jacksonville, FL, USA.ORCID 0000-0002-9851-985X
Han W TunDivision of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.ORCID 0000-0002-9184-094X
Jacksonville College · USMayo Clinic in Florida · USJacksonville University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cauda equina lymphoma is an extremely rare entity previously documented in only 24 reported cases. Primary cauda equina lymphoma represents a subtype of neurolymphomatosis, which occurs when lymphoma cells with neurotropism infiltrate and destroy peripheral nerves, spinal nerve roots, nerve plexuses and cranial nerves. The cauda equina is an anatomic structure located in the lower part of the spinal canal consisting of multiple lumbar and sacral nerve roots. Herein, we report a unique case of primary cauda equina diffuse large B-cell lymphoma presenting as a tumor mass in the lower spinal canal, which was treated with a CNS-centric treatment approach followed by autologous hematopoietic stem cell transplantation.

Indexed as

autologous stem cell transplantdiffuse large B cell cauda equina lymphomaMATRIX chemoimmunotherapyneurolymphomatosisprimary cauda equina lymphoma

Identifiers

PMID34321945
PMCPMC8312505
OpenAlexW3183580255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.